Kamal K. Mubarak - Concepedia

Author

Kamal K. Mubarak

University of Florida

Also Known As

Barst, Robyn J., KAMAL K. MUBARAK, Kamal K Mubarak, Kamal K. Mubarak, Kamal Mubarak, Kamal K. Mubarak

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

University of Florida Wayne State University Johns Hopkins University Medical University of South Carolina University of California, San Francisco

About

Kamal K. Mubarak is an author at University of Florida specializing in medicine, pulmonary hypertension, and pulmonary vascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	424
2	Public Health	2	2	100
3	Engineering	1	1	17
4	Health Sciences	1	1	128
5	Social Sciences	1	1	17

Kamal K. Mubarak

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Cyclophosphamide versus Placebo in Scleroderma Lung Disease Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, New England Journal of Medicine	2006	1.6K
Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements, American Journal of Respiratory and Critical Care Medicine	2007	463
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease Elizabeth S. Klings, Roberto F. Machado, Robyn J. Barst, American Journal of Respiratory and Critical Care Medicine	2014	248
Diminazene Attenuates Pulmonary Hypertension and Improves Angiogenic Progenitor Cell Functions in Experimental Models Vinayak Shenoy, Altin Gjymishka, Yagna Jarajapu, American Journal of Respiratory and Critical Care Medicine	2013	173
Correlation of the degree of dyspnea with health‐related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung study Dinesh Khanna, Philip J. Clements, Daniel E. Fürst, Arthritis & Rheumatism	2005	134
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies Robyn J. Barst, Kamal K. Mubarak, Roberto F. Machado, British Journal of Haematology HypertensionWeek 16Pulmonary HypertensionExerciseHematology	2010	128
Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-β1 in vitro Najmunnisa Nasreen, Kamal A. Mohammed, Kamal K. Mubarak, American Journal of Physiology-Lung Cellular and Molecular Physiology Lung InflammationImmunologyPathologyCell ProliferationCellular Physiology	2009	107
Impact of oral cyclophosphamide on health‐related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study Dinesh Khanna, Xiaohong Yan, Donald P. Tashkin, Arthritis & Rheumatism	2007	96
<i>Mycobacterium</i>‐Mediated Chemokine Expression in Pleural Mesothelial Cells: Role of C‐C Chemokines in Tuberculous Pleurisy Kamal A. Mohammed, Najmunnisa Nasreen, Melissa J. Ward, The Journal of Infectious Diseases	1998	68
Effect of Balloon Inflation Volume on Pulmonary Artery Occlusion Pressure in Patients With and Without Pulmonary Hypertension Adriano R. Tonelli, Kamal K. Mubarak, Ning Li, CHEST Journal HypertensionPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseVascular Surgery	2011	52

Page 1